Sang-we Kim

基本信息

浏览量：341

职业迁徙

个人简介

Specialty
Lung Cancer, Thymus Tumor, Malignant Mesothelioma, Neurological Cancer

研究兴趣

论文共 458 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2024)

引用0浏览0WOS引用

Avelumab in Combination with Lorlatinib or Crizotinib in Patients with Previously Treated Advanced NSCLC: Phase 1b/2 Results from the JAVELIN Lung 101 Trial

Benjamin J. Solomon,Ibiayi Dagogo-Jack,Se-Hoon Lee,Michael J. Boyer,Suresh S. Ramalingam,Enric Carcereny,Enriqueta Felip,Ji-Youn Han,Toyoaki Hida,Brett G. M. Hughes,Sang -We Kim,Makoto Nishio,Takashi Seto,Tatsuro Okamoto,Xiaoxi Zhang,Jean -Francois Martini, Erjian Wang, Steven De Beukelaer,Todd M. Bauer

JTO CLINICAL AND RESEARCH REPORTSno. 7 (2024)

引用0浏览0WOS引用

Abstract 4998: Pralsetinib Induces Opportunistic Infection in RET Fusion-Positive NSCLC Patients Via Inhibition of IL-2 Production by Blocking Jak3-Stat5 Activation

Shinkyo Yoon,Hyun-Min Ryu,Sang-We Kim,Kang-Seo Park,Dae Ho Lee

Cancer Researchno. 6_Supplement (2024): 4998-4998

引用0浏览0引用

Updated Overall Survival and Ctdna Analysis in Patients with EGFR T790M-positive Advanced Non-Small Cell Lung Cancer Treated with Lazertinib in the Phase 1/2 LASER201 Study

Ji-Youn Han,Myung-Ju Ahn,Ki Hyeong Lee,Yun-Gyoo Lee,Dong-Wan Kim,Young Joo Min,Sang-We Kim,Eun Kyung Cho,Joo-Hang Kim, Gyeong-Won Lee,Sung Sook Lee, Na Mi Lee,Hyun Woo Jang, Heewon Han, Hyejoo Park, Jieon Lee,Byoung Chul Cho

BMC Medicineno. 1 (2024): 1-10

引用0浏览0WOS引用

A Phase II, Open-Label, Single-Arm, Multicenter, Efficacy and Safety Study of 80 Mg Osimertinib in Patients with Leptomeningeal Metastases (LM) Associated with Epidermal Growth Factor Receptor (EGFR) Mutation–positive Non-Small Cell Lung Cancer (NSCLC): BLOSSOM

Myung-Ju Ahn,Sehhoon Park, Richard Baldry,Hyun Ae Jung,Jong-Mu Sun,Se-Hoon Lee, Jin Seok Ahn,Yu Jung Kim, Youngjoo Lee,Dong-Wan Kim,Sang-We Kim,Ki Hyeong Lee,Nak-Hoon Son

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Canakinumab Versus Placebo in Combination with First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results from the CANOPY-1 Trial

JOURNAL OF CLINICAL ONCOLOGYno. 2 (2024)

引用0浏览0WOS引用

Durvalumab in Combination with Chemoradiotherapy for Patients with Unresectable Stage III Non-Small-cell Lung Cancer: Results from the Phase 1 CLOVER Study

Dong-Wan Kim,Byoung Chul Cho, Krishna Pachipala,Sang-We Kim,Chih-Liang Wang,Gee -Chen Chang,Myung-Ju Ahn,Rosa Alvarez,Chao-Hua Chiu,Jose Trigo,Anna Estival,Sana D. Karam,Cathy O'Brien,Hema Gowda,Haiyi Jiang,Julie E. Bauman

LUNG CANCER (2024)

引用0浏览0WOS引用

Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer: Single-Institution Experience

So Heun Lee,Hyehyun Jeong,Deok Hoon Kim,Se Jin Jang,Sang-We Kim,Shinkyo Yoon,Dae Ho Lee

CANCER RESEARCH AND TREATMENTno. 3 (2024): 774-784

引用0浏览0WOS引用

Repotrectinib in Tyrosine Kinase Inhibitor (Tki)-Naïve Patients (pts) with Advanced ROS1 Fusion-Positive (ROS1+) NSCLC in the Phase 1/2 TRIDENT-1 Trial: Clinical Update, Treatment Beyond Progression and Subsequent Therapies

Alexander E. Drilon,Rafal Dziadziuszko,David Ross Camidge,Jessica Jiyeong Lin,Benjamin Besse,Sang-We Kim,Ki Hyeong Lee,Benjamin J. Solomon,Misako Nagasaka,Koichi Goto,Juergen Wolf,Adrianus Johannes De langen,Parneet Kaur Cheema,Nong Yang, Vamsidhar Velcheti,Yasir Y. Elamin, Yuanfang Xu, Christophe Calvet,Felipe Ades,Byoung Chul Cho

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 458 篇作者统计合作学者相似作者